Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peri-operative versus post-operative chemotherapy scheduling for operable colorectal liver metastases
2011-003052-40Phase 2Terminated
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Aug 2011
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of oxaliplatin, irinotecan, folinic acid, fluorouracil and capecitabine in colorectal cancer (CRC) (2 arms), sponsored by University Hospital Southampton NHS Foundation Trust. Primary endpoint: Feasibility of recruitment. Started Aug 2011; status: terminated.
02
Drugs
oxaliplatinirinotecanfolinic acidfluorouracilcapecitabine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2011-003052-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003052-40.